$name

Back

SANTA MONICA, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), today announced that it will release first quarter 2015 financial results on Friday, May 15, 2015.

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA.

CONTACT: Kite PharmaCynthia M. Butitta

         Chief Financial Officer and Chief Operating Officer

         310-824-9999



         For Media: Justin Jackson

         For Investor Inquiries: Lisa Burns and Carol WertherBurns McClellan

         212-213-0006

         jjackson@burnsmc.comlburns@burnsmc.comcwerther@burnsmc.com

Kite Pharma, Inc.

News Provided by Acquire Media